NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Personal Services · USD

Medifast, Inc. (MED) Stock Analysis

Medifast, Inc. (MED) is a Personal Services stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

MED

$12.10

+$0.04 (+0.33%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MED with… →

MED Key Statistics

As of Oct 21, 2026
Trading
Open
$12.14
Previous Close
$12.06
Day's Range
11.93–12.13
52-Week Range
9.22–13.45
Volume
135.43K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.70
Valuation
Market Cap
$135.29M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.97
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.43
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.33
Financials (FY)
Revenue (FY)
$385.79M−35.96%
Net Income (FY)
−$18.67M−992.97%
Profit marginThe share of revenue left as profit after all costs and taxes.
−8.08%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
11.18M
1-Year Return
−5.98%
Dividend and dates
Earnings Date
October 26, 2026
Avg Volume
142.61K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, MED closed at $12.10, −5.98% over 1 year.

Medifast, Inc. (MED) has a market capitalization of $135.29M.

In fiscal 2025, MED reported revenue of $385.79M.

MED Stock Return by Calendar Year

Medifast, Inc. (MED) 10-year return: what $10,000 became

1 year
$10,000 $9,402
−5.98%
5 years
$10,000 $677
−93.23%
10 years
$10,000 $3,788
−62.12%

If you had invested $10,000 in Medifast, Inc. (MED) 10 years ago, at the close on October 21, 2016, it would have been worth $3,788 at the close on October 21, 2026: −62.12% in total, −9.25% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+13.30%
2025−39.39%
2024−73.79%
2023−38.34%
2022−42.31%
2021+9.36%
2020+86.18%
2019−9.73%
2018+82.11%
2017+72.33%
2016 (partial year)+19.75%

As of October 21, 2026.

MED Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$385.79M−$18.67M−4.8%
2024$602.46M$2.09M0.3%
2023$1.07B$99.42M9.3%
2022$1.60B$143.57M9.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$385.79M$275.19M−$14.21M−$18.67M−4.8%
2024$602.46M$444.62M$2.88M$2.09M0.3%
2023$1.07B$775.85M$126.40M$99.42M9.3%
2022$1.60B$1.14B$184.81M$143.57M9.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MED Dividend History

$4.95−24.5% vs 2022

Dividends per share, 2023 · 3 payments

YearDividends per sharePaymentsChange
2023$4.953−24.5%
2022$6.564+15.5%
2021$5.684+25.7%
2020$4.524+33.7%
YearDividends per sharePaymentsChange
2023$4.953−24.5%
2022$6.564+15.5%
2021$5.684+25.7%
2020$4.524+33.7%
2019$3.384+54.3%
2018$2.194+52.1%
2017$1.444+350.0%
2016$0.321—

Most recent payment: $1.65 per share, ex-dividend September 18, 2023. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

MED Valuation vs Personal Services Median

Median of 14 stocks
MetricMEDPersonal Services medianvs median
P/S ratio0.431.1161% below
Profit margin−8.08%3.88%12.0 pts below

Medians across 14 Personal Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 10 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Medifast, Inc. (MED) carries a market capitalisation of $135.29M. The company sits in the Consumer Cyclical sector, in the Personal Services industry. Headcount on file is 380.

The most recent close on file for MED is $12.10, dated October 21, 2026. That is +$0.04 (+0.33%) against the previous close. Over the past 52 weeks the price has ranged from $9.22 to $13.45. The latest close sits 31.24% above that 52-week low.

Financial Health

In fiscal 2025, Medifast, Inc. reported revenue of $385.79M. Against the prior fiscal year total of $602.46M, that is a change of −35.96%. The same year closed with a net loss of $18.67M. The reported profit margin is −8.08%. That is 12 percentage points below the Personal Services median of 3.88%. Trailing earnings per share are −2.33.

Across the 4 fiscal years on file, revenue moves from $1.60B in 2022 to $385.79M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.97. Measured against sales, the shares trade at 0.43 times revenue. On price-to-sales that is 61.49% below the Personal Services median of 1.11. The medians here are taken across 14 Personal Services companies that report the metric.

Over the trailing twelve months the total return is −5.98%. Across 10 years the annualized return works out at −9.25%. Beta against the wider market is reported at 0.7. Annualized volatility over the trailing 10 years is 49.24%.

Growth & Income

The dividend record for MED runs through 2023. Dividends are recorded for 8 calendar years; 2023 shows 3 payments totalling $4.95 a share. The year before, 2022, totalled $6.56 a share.

So far in 2026 the total return is +13.30%. The strongest complete calendar year on file is 2020 at +86.18%; the weakest is 2024 at −73.79%. Of the 9 complete calendar years on file, 4 finished higher.

Peer Comparison

Medifast, Inc. (MED) operates in the Personal Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Medifast, Inc. MED $135.29M —
Rollins, Inc. ROL $16.09B 30.4
Service Corporation International SCI $11.06B 21.3
H&R Block, Inc. HRB $5.86B 8.4

The Personal Services industry average P/E ratio is 19.8x. Medifast, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Personal Services Stocks

ROL

Rollins, Inc.

$16.09B

 SCI

Service Corporation International

$11.06B

 HRB

H&R Block, Inc.

$5.86B

 FTDR

Frontdoor, Inc.

$5.57B

 BFAM

Bright Horizons Family Solutions Inc.

$3.36B

 ANDG

Andersen Group Inc.

$1.13B
View all Personal Services stocks →

Popular Consumer Cyclical Stocks

AMZN

Amazon.com, Inc.

$2.83T

 TSLA

Tesla, Inc.

$1.53T

 HD

The Home Depot, Inc.

$313.41B

 BABA

Alibaba Group Holding Limited

$270.19B

 TM

Toyota Motor Corporation

$229.51B
View all Consumer Cyclical stocks →

About Medifast, Inc.

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Visit website →